Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Spotlight on Transdermal Fentanyl in Chronic Cancer Pain

Spotlight on Transdermal Fentanyl in Chronic Cancer Pain Fentanyl is a synthetic opioid agonist which interacts primarily with the µ-opioid receptor. The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for delivery by the transdermal therapeutic system. These patches are designed to deliver fentanyl at a constant rate (25, 50, 75 and 100 µg/h), and require replacement every 3 days. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Spotlight on Transdermal Fentanyl in Chronic Cancer Pain

Loading next page...
 
/lp/springer-journals/spotlight-on-transdermal-fentanyl-in-chronic-cancer-pain-xKrt03qAaY
Publisher
Springer Journals
Copyright
Copyright © 2002 by Adis International Limited
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200201020-00008
Publisher site
See Article on Publisher Site

Abstract

Fentanyl is a synthetic opioid agonist which interacts primarily with the µ-opioid receptor. The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for delivery by the transdermal therapeutic system. These patches are designed to deliver fentanyl at a constant rate (25, 50, 75 and 100 µg/h), and require replacement every 3 days.

Journal

American Journal of CancerSpringer Journals

Published: Aug 9, 2012

References